Understanding how psychedelic drugs affect brain and behaviour in rodents

MRC · United Kingdom government procurement

Closed September 29, 2027. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

The profound perception-, emotion- and cognition-altering properties of psychedelic drugs have been hailed as a "breakthrough therapy" for pervasive, difficult-to-treat neuropsychiatric conditions such as major depressive disorder. As such, drugs such as psilocybin have unique potential to treat the causes of psychiatric illness and enable recovery (1). However, the mechanisms by which psychedelics impact brain function remain poorly understood.

In human diseases such as major depression the communication between brain regions appears to become too rigid. This results in patients being 'stuck in a rut', unable to 'break out' of repetitive negative thoughts and feelings as well as expressing high anxiety, poor self-esteem and self-blaming. These thought patterns may arise from the abnormal dominance of certain brain states, often due to hyperactive 'top down' focus on negative thoughts. Psychedelics may act to reverse this state by increasing the variety of brain states through temporarily reorganizing how brain regions interact, thereby, enabling the formation of new, long-range communication patterns (1, 2). This, in turn, may lead to more flexible cognition and emotional breakthroughs in patients (3). Such an effect may 're-program' maladaptive thinking patterns by enhancing bottom-up information transmission, allowing the emergence of a new, potentially brighter, cognitive perspective (4). However, it is difficult to investigate this hypothesis purely via human brain scanning, as this is an indirect measure of brain activity; thus, invasive approaches to record the activity of neurons directly are required and this can only be accomplished using rodents.

To reveal the neural and synaptic effects of psychedelics the student on this project will record from multiple regions of the rodent brain during psychedelic drug challenge. Recordings will target brain regions including the prefrontal and parietal cortices, hippocampus and amygdala, as well as...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedSeptember 30, 2023
Procurement stageActive solicitation
ClosedSeptember 29, 2027
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedAugust 10, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Browse Similar Open Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Dectin-1-mediated suppression of protective anti-mycobacterial immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.